Cryotherapy or cervical cancer screening in HIV-infected women?

Cryotherapy or cervical cancer screening in HIV-infected women? PharmacoEconomics & Outcomes News 784, p11 - 12 Aug 2017 Cryotherapy or cervical cancer screening in HIV-infected women? Preventative cryotherapy without screening is less costly for preventing cervical cancer in HIV-infected women and leads to higher life expectancy than screening strategies, according to the results of a study conducted in Kenya. The study used a Markov model to assess health outcomes and costs of the following strategies for preventing cervical cancer: 1) screening strategies including Papanicolaou (Pap) smear, visual inspection with acetic acid (VIA), human papillomavirus (HPV) testing, Pap + HPV and VIA + Pap; or 2) preventative cryotherapy without screening. The model was populated with clinical and resource-use data from a study of cervical cancer screening conducted at an HIV treatment clinic in Nairobi, Kenya. The model showed that cryotherapy without screening had the lowest mean lifetime cost of screening and treatment, compared with VIA, Pap screening and HPV screening ($US99 vs $196, $219 and $223, respectively, from a societal perspective; and $19 vs $94, $124 and $113, respectively, from a clinic perspective) and the highest life expectancy (17.3 vs 17.1 years). Among the screening strategies, VIA had the lowest cost with the highest life expectancy. However, if HPV screening could be reduced to a single-visit strategy, it would be less costly than VIA. Cryotherapy "merits further investigation as a treatment tool that could help all women enrolled in an HIV clinic," suggest the researchers. Zimmermann MR, et al. Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya. Cost Effectiveness and Resource Allocation : 14 Jul 2017. Available from: URL: https:// 803261913 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784 PharmacoEconomics & Outcomes News Springer Journals

Cryotherapy or cervical cancer screening in HIV-infected women?

1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial